reports
BRT Apartments Corp. Completes Debt Refinancings
BRT Apartments Corp. Completes Debt Refinancings GREAT NECK, N.Y., Dec. 17, 2025 (GLOBE NEWSWIRE) -- BRT APARTMENTS CORP. (NYSE: BRT) announced today that it has successfully completed the refinancing of three mortgages mentioned in the Company’s most recent 10-Q filing. The three maturing mortgages in the aggregate amount of $42.7 million and bearing a weighted average interest rate of 4.36% were refinanced through new mortgage debt in the aggregate amount of approximately $71.9 million, with a weighted average remaining term to maturity of approximately nine years and a weighted averag...
- Wedbush Research
- Chase Tohanczyn
- Daniel Ives
- Matthew Weiss
- Scott Devitt
Takeaways from AV Regulatory Expert Call
Motor vehicles, including AVs, face different regulations at the federal, state, and local levels. At the federal level, the NHTSA issues the Federal Motor Vehicle Safety Standards (FMVSS), regulating the design, construction, and performance of vehicles. At the state level, regulators govern traff
Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recu...
Greenwich LifeSciences Announces Preliminary Analysis Showing 80% Recurrence Rate Reduction in the Open Label Arm of FLAMINGO-01 STAFFORD, Texas, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced an approximately 80% recurrence rate reduction in the open label non-HLA-A*02 arm of FLAMINGO-01. A preliminary analysis of recurrence rates by two methods...
- Anish Jog
- Chase Tohanczyn
- Daniel Ives
- Matthew Weiss
- Sam Brandeis
- Scott Devitt
- Steven Wahrhaftig
STARTING SOON: Autonomous Vehicle Regulatory Expert Call | TODAY | 2PM...
Before that, he served as Senior Counselor to the Administrator at the White House’s Office of Information and Regulatory Affairs, where he led high-impact regulatory initiatives across a broad portfolio that included transportation, health, labor, education, agriculture, veterans, and defense; dev
- Chase Tohanczyn
- Daniel Ives
- Matthew Weiss
- Scott Devitt
STARTING SOON: Autonomous Vehicle Regulatory Expert Call | TODAY | 2PM...
Before that, he served as Senior Counselor to the Administrator at the White House’s Office of Information and Regulatory Affairs, where he led high-impact regulatory initiatives across a broad portfolio that included transportation, health, labor, education, agriculture, veterans, and defense; dev
- Wedbush Research
TSLA TESLA INC
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
NRZ NEW RESIDENTIAL INVESTMENT CORP.
MU MICRON TECHNOLOGY INC.
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
AXTI AXT INC.
7974 NINTENDO CO. LTD.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
WVE WAVE LIFE SCIENCES
ROKU ROKU INC. CLASS A
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
NICE NICE LTD
LYFT LYFT
PINS PINTEREST INC. CLASS A
UBER UBER TECHNOLOGIES INC.
U UNITY SOFTWARE
DASH DOORDASH
VRDN VIRIDIAN THERAPEUTICS INC
STX SEAGATE TECHNOLOGY HLDGS PLC
APP APPLOVIN CORP
TTD THE TRADE DESK
GFS INC.
CART GLOBALFOUNDRIES INC
DBD MAPLEBEAR INC.
DIEBOLD NIXDORF INCORPORATED
- Chase Tohanczyn
- Daniel Ives
- Matthew Weiss
- Scott Devitt
Takeaways from Advisor Call: Early Days for Autonomous
The different approaches to technical AV development will remain a key area of debate. Tesla and Waymo have adopted vastly different approaches on autonomous vehicle development. Tesla has utilized a lower-cost system relying primarily on cameras and AI-based software. Early in its AV development,
- Chase Tohanczyn
- Daniel Ives
- Matthew Weiss
- Scott Devitt
STARTING SOON: Autonomous Vehicle Tech Expert Call | TODAY | 10AM ET
Before joining Cruise, Mehrdad spent close to three years at Waymo, Google's self-driving car division, as Tech Lead Manager for AI Systems, focused on building and validating safety-critical capabilities for autonomous mobility. Prior to that, he was a Senior Autonomous Vehicles Research Engineer
- Chase Tohanczyn
- Daniel Ives
- Matthew Weiss
- Scott Devitt
REMINDER: Autonomous Vehicle Regulatory Expert Call | Dec. 15 | 2PM ET
Before that, he served as Senior Counselor to the Administrator at the White House’s Office of Information and Regulatory Affairs, where he led high-impact regulatory initiatives across a broad portfolio that included transportation, health, labor, education, agriculture, veterans, and defense; dev
- Chase Tohanczyn
- Daniel Ives
- Matthew Weiss
- Scott Devitt
REMINDER: Autonomous Vehicle Tech Expert Call | December 12 | 10AM ET
Before joining Cruise, Mehrdad spent close to three years at Waymo, Google's self-driving car division, as Tech Lead Manager for AI Systems, focused on building and validating safety-critical capabilities for autonomous mobility. Prior to that, he was a Senior Autonomous Vehicles Research Engineer
BRT Apartments Corp. Announces Quarterly Dividend
BRT Apartments Corp. Announces Quarterly Dividend GREAT NECK, New York, Dec. 10, 2025 (GLOBE NEWSWIRE) -- BRT APARTMENTS CORP. (NYSE: BRT) announced today that its Board of Directors declared a quarterly dividend of $0.25 per share. The dividend is payable January 6, 2026, to stockholders of record at the close of business on December 22, 2025. The Company estimates that for federal income tax purposes, all of this dividend will be included in 2026 taxable income and that all of the dividends paid in 2025 will be treated as a return of capital. BRT is a real estate investment trust that ...
- Chase Tohanczyn
- Matthew Weiss
- Scott Devitt
- Chase Tohanczyn
- Daniel Ives
- Matthew Weiss
- Scott Devitt
Wedbush Invite: Autonomous Vehicle Regulatory Expert Call | Dec. 15 | ...
Varun was most recently a Deputy General Counsel at the US Department of Transportation, where he provided strategic guidance on regulation, consumer protection, and other matters as well as helped oversee a departmental legal team of nearly 500 attorneys. Before that, Varun served as Senior Counse
- Wedbush Research
SRPT SAREPTA THERAPEUTICS INC.
KURA KURA ONCOLOGY INC.
GOOGL ALPHABET INC. CLASS A
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
AMZN AMAZON.COM INC.
ARVN ARVINAS HOLDING
LYFT LYFT
UBER UBER TECHNOLOGIES INC.
BEAM BEAM THERAPEUTICS
COGT COGENT BIOSCIENCES INC
DASH DOORDASH
IMNM IMMUNOME
SANA SANA BIOTECHNOLOGY
CGEM CULLINAN ONCOLOGY INC
TCRX TSCAN THERAPEUTICS INC
GMTX GEMINI THERAPEUTICS INC
PRME PRIME MEDICINE INC
CART MAPLEBEAR INC.
- Chase Tohanczyn
- Daniel Ives
- Matthew Weiss
- Scott Devitt
Wedbush Invite: Autonomous Vehicle Tech Expert Call | December 12 | 10...
Before joining Cruise, Mehrdad spent close to three years at Waymo, Google's self-driving car division, as Tech Lead Manager for AI Systems, focused on building and validating safety-critical capabilities for autonomous mobility. Prior to that, he was a Senior Autonomous Vehicles Research Engineer
Greenwich LifeSciences Announces Completion of Enrollment in the Open ...
Greenwich LifeSciences Announces Completion of Enrollment in the Open Label Arm of FLAMINGO-01 STAFFORD, Texas, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced the completion of enrollment in the open label non-HLA-A*02 arm of FLAMINGO-01. In the double-blinded arms of the Phase III trial, approximately 500 HLA-A*02 patients are currently planned...
Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screenin...
Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date STAFFORD, Texas, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences, today provided the following global update on FLAMINGO-01. Flamingo-01 Progress to Date The Company has achieved a major milestone by screening over 1,000 patients in Flamingo-01, continuing its scr...
- Wedbush Research
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
CDR CD PROJEKT S.A.
7974 NINTENDO CO. LTD.
EA ELECTRONIC ARTS INC.
AMZN AMAZON.COM INC.
UBER UBER TECHNOLOGIES INC.
U UNITY SOFTWARE
DASH DOORDASH
PLTK PLAYTIKA HOLDING
RBLX ROBLOX
APP APPLOVIN CORP
JANX JANUX THERAPEUTICS INC
DDI DOUBLEDOWN INTERACTIVE CO LTD
EMBRAC B EMBRACER GROUP AB
CART MAPLEBEAR INC.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.